DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma

Information source: Merck
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Asthma, Bronchial

Intervention: MK0476, montelukast sodium / Duration of Treatment: 1 Year (Drug); Comparator : fluticasone propionate / Duration of Treatment: 1 Year (Drug)

Phase: Phase 3

Status: Completed

Sponsored by: Merck

Official(s) and/or principal investigator(s):
Medical Monitor, Study Director, Affiliation: Merck

Summary

A study to evaluate MK0476 and Fluticasone to control asthma in patients with mild persistent asthma.

Clinical Details

Official title: A Double-Blind, Randomized, Double-Dummy, Multicenter Study to Evaluate and Compare Oral Montelukast and Inhaled Fluticasone in the Control of Asthma for 6- to 14-Year-Olds With Mild Persistent Asthma

Study design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: Improvement of asthma with MK0476 and Fluticasone as measured by number of asthma rescue-free days

Secondary outcome: Improved effect of MK0476 and fluticasone on FEV1 values

Eligibility

Minimum age: 6 Years. Maximum age: 14 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patient is male or female, 6-14 years of age with mild persistent asthma

- Patient has a history of the following symptoms: wheezing, chest tightness, cough,

etc.

- Patient has asthma diagnosed by a doctor

Exclusion Criteria:

- Patient is hospitalized

- Patient has had major surgery or participated in another clinical trial in the last 4

weeks

- Patient has been on a breathing tube for asthma

Locations and Contacts

Additional Information

Related publications:

Garcia Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics. 2005 Aug;116(2):360-9. Erratum in: Pediatrics. 2005 Oct;116(4):1058.

Starting date: July 2001
Ending date: June 2003
Last updated: October 8, 2007

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012